Protagonist Therapeutics, Inc PTGX
$140.90
-0.68%
at last close
Financials (TTM)
- Revenue
- $281.99 million
- Net Income
- $82.91 million
- Net Margin
- 29.40%
- Return on Equity
- 9.85%
- Debt-to-Equity
- —
- P/E Ratio
- 138.14
- Price / Book
- 10.91
- Price / Sales
- 32.55
Over the trailing twelve months, Protagonist Therapeutics, Inc generated revenue of $281.99 million and net income of $82.91 million, a net margin of 29.40%.
At the last closing price of $140.90, PTGX trades at 138.14 times trailing earnings and 32.55 times sales, with a market capitalization of $9.18 billion.
Key Stats
- Last Close
- $140.90
- Market Cap
- $9.18 billion
- 52-Week Range
- $54.50 – $160.81
- Average Volume
- 602K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.